Should living kidney donors with hypertension be considered for organ donation?

Current Opinion in Nephrology and Hypertension

Volumn 24, Issue 6, 2015, Pages 594-601

  Townsend, Raymond R ^a   Reese, Peter P ^a,b   Lim, Mary Ann ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular risk; Chronic kidney disease; Hypertension; Living kidney donation

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; END STAGE RENAL DISEASE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DONOR; KIDNEY GRAFT; LIVING DONOR; NEPHRECTOMY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; COMPLICATION; GLOMERULUS FILTRATION RATE; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSPLANTATION;

GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT;

EID: 84944069793     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0000000000000169     Document Type: Review

References (36)

1. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. Clin Nephrol 1996; 334:13-18.
2. Whelton PK, He J, Perneger TV, Klag MJ. Kidney damage in 'benign' essential hypertension. Curr Opin Nephrol Hypertens 1997; 6:177-183.
3. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and riskof coronary heart disease. The Framingham study. Am J Cardiol 1971; 27:335-346.
4. Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am J Med 1984; 76 (Suppl 2A):4-12.
5. Lenihan CR, Busque S, Derby G, et al. The association of predonation hypertension with glomerular function and number in older living kidney donors. J Am Soc Nephrol 2015; 26:1261-1267.
6. Piper MA, Evans CV, Burda BU, et al. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening inter vals: a systematic review for the U.S. Preventive services task force. Ann Intern Med 2015; 162:192-204.
7. Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011; 171:1090-1098.
8. Chahine MN, Assemaani N, Sayed HG, et al. Validation of the OMRON M3500 blood pressure measuring device using normal-and high-speed modes in adult and specific populations (obese and children) According to AAMI Protocol. J Clin Hypertens (Greenwich) 2015; 17:622-629.
9. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005; 46:156-161.
10. Bobrie G, Clerson P, Menard J, et al. Masked hypertension: a systematic review. J Hypertens 2008; 26:1715-1725.
11. Boudville N, Prasad GV, Knoll G, et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006; 145:185-196.
12. Goldfarb DA, Matin SF, Braun WE, et al. Renal outcome 25 years after donor nephrectomy. J Urol 2001; 166:2043-2047.
13. Gossmann J, Wilhelm A, Kachel HG, et al. Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant 2005; 5:2417-2424.
14. Mjoen G, Midtvedt K, Holme I, et al. One-and five-year follow-ups on blood pressure and renal function in kidney donors. Transpl Int 2011; 24:73-77.
15. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet 1992; 340:807-810.
16. Prasad GV, Lipszyc D, Huang M, et al. A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation 2008; 86:1315-1318.
17. Santos L, Macario F, Alves R, et al. Risks of living donor nephrectomy. Transplant Proc 2010; 42:1484-1486.
18. Garg AX, Prasad GV, Thiessen-Philbrook HR, et al. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86:399-406.
19. Tsinalis D, Binet I, Steliger J. Can 'borderline' living kidney donors (BLKD) be used safely for transplantation? [abstract]. Kidney Blood Pressure Res 1999; 22:388-389.
20. Kumar A, Das SK, Srivastava A. Expanding the living related donor pool in renal transplantation: use of marginal donors. Transplant Proc 2003; 35:28-29.
21. Gracida C, Espinoza R, Cedillo U, Cancino J. Kidney transplantation with living donors: nine years of follow-up of 628 living donors. Transplant Proc 2003; 35:946-947.
22. Textor SC, Taler SJ, Driscoll N, et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004; 78:276-282.
23. Srivastava A, Sinha T, Varma PP, et al. Experience with marginal living related kidney donors: are they becoming routine or are there still any doubts? Urology 2005; 66:971-975.
24. Tent H, Sanders JS, Rook M, et al. Effects of preexistent hypertension on blood pressure and residual renal function after donor nephrectomy. Transplantation 2012; 93:412-417.
25. Sofue T, Inui M, Hara T, et al. Short-term prognosis of living-donor kidney transplantation from hypertensive donors with high-normal albuminuria. Transplantation 2014; 97:104-110.
26. Young A, Storsley L, Garg AX, et al. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant 2008; 8:1878-1890.
27. Issa N, Stephany B, Fatica R. Donor factors influencing graft outomes in live donor kidney transplantation. Transplantation 2007; 83:593-599.
28. Sofue T, Inui M, Kiyomoto H, et al. Preexisting arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function. Am J Nephrol 2012; 36:127-135.
29. OPTN, SRTR. Annual Data Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. http://srtr.transplant.hrsa.gov/annual-reports/2012/pdf/01-kidney-13.pdf. 2012. [Accessed 1 August 2015].
30. Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12:589-597.
31. Merion RM, Ashby VB, Wolfe RA, et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294:2726-2733.
32. Section II: Evaluation and selection of donors. Nephrol Dial Transplant 2000; 15:39-51.
33. Delmonico F. A Report of the Amsterdam Forum On the Care of the Live Kidney Donor: data and medical guidelines. Transplantation 2005; 79:S53-S66.
34. United Kingdom Guidelines for Living Donor Kidney Transplantation. https://www.bts.org.uk/BTS/Guidelines-Standards/Current-Guidleines.aspx. 2011. [Accessed 1 August 2015].
35. Evaluation of Living Kidney Donor-a Consensus Document from the American Society of Transplant/American Society of Transplant Surgeons/Organization of Transplant Professionals/United Network of Organ Sharing Joint Societies Work Group. http://optn.transplant.hrsa.gov/PublicComment/pubcommentPropSurveyExhibit-38.pdf. 2010. [Accessed 1 August 2015].
36. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311:507-520.